These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 11281402

  • 1. The marginal success of regulated competition policy in the Netherlands.
    Lieverdink H.
    Soc Sci Med; 2001 Apr; 52(8):1183-94. PubMed ID: 11281402
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Managed competition and consumer price sensitivity in social health insurance.
    Schut FT, Hassink WH.
    J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Seeing difference: market health reform in Europe.
    Jacobs A.
    J Health Polit Policy Law; 1998 Feb; 23(1):1-33. PubMed ID: 9522279
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Free choice of sickness funds in regulated competition: evidence from Germany and The Netherlands.
    Gress S, Groenewegen P, Kerssens J, Braun B, Wasem J.
    Health Policy; 2002 Jun; 60(3):235-54. PubMed ID: 11965333
    [Abstract] [Full Text] [Related]

  • 12. Belgium and The Netherlands revisited.
    van Doorslaer E, Schut FT.
    J Health Polit Policy Law; 2000 Oct; 25(5):875-87. PubMed ID: 11068731
    [No Abstract] [Full Text] [Related]

  • 13. Market competition: everybody is talking, but what do they say?. A sociological analysis of market competition in policy networks.
    Paulus A, van Raak A, van der Made J, Mur-Veeman I.
    Health Policy; 2003 Jun; 64(3):279-89. PubMed ID: 12745167
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Managed competition in the Netherlands-a qualitative study.
    Heinemann S, Leiber S, Gress S.
    Health Policy; 2013 Feb; 109(2):113-21. PubMed ID: 23031431
    [Abstract] [Full Text] [Related]

  • 17. Managing the health care market in developing countries: prospects and problems.
    Broomberg J.
    Health Policy Plan; 1994 Sep; 9(3):237-51. PubMed ID: 10137740
    [Abstract] [Full Text] [Related]

  • 18. Risk adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the Netherlands.
    Lamers LM, van Vliet RC, van de Ven WP.
    Health Policy; 2003 Jul; 65(1):49-62. PubMed ID: 12818745
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Managed competition, governmentality and institutional response in the United Kingdom.
    Light DW.
    Soc Sci Med; 2001 Apr; 52(8):1167-81. PubMed ID: 11281401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.